ACX develops sustainable, eco-friendly biocides as alternatives to traditional chemical pesticides for precision agriculture. Their proprietary platform integrates bioengineering, bioformulation optimization, and AI to create innovative crop protection solutions. These biocides deliver superior performance, leading to improved plant health, increased crop yields, and enhanced resilience against environmental stressors.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
The rise of antibiotic-resistant bacteria poses a significant threat to global health, demanding innovative approaches to combat infections. Traditional antibiotics are becoming less effective, necessitating the development of new antimicrobial agents with novel mechanisms of action.
Solution
ACX is developing a new class of therapeutics based on synthetic compounds that mimic the natural strategies bacteria use to target and eliminate harmful microbes. By recreating these compounds, ACX aims to create effective antimicrobial agents that can overcome existing resistance mechanisms. This approach offers a potential solution to the growing problem of antibiotic resistance by providing new tools to combat bacterial infections.
Target Audience
ACX's primary target audience includes pharmaceutical companies and research institutions focused on developing novel antimicrobial therapies.
Features
- Synthetic compounds mimicking naturally occurring bacterial antimicrobial agents
- Novel mechanisms of action to bypass existing antibiotic resistance
- Potential for broad-spectrum activity against various bacterial pathogens